OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
Maria Vulf, Daria Skuratovskaia, Alexandra Komar, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 25

Showing 25 citing articles:

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 38

Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Shreya C. Pal, Mohammed Eslam, Nahúm Méndez‐Sánchez
HORMONES (2022) Vol. 21, Iss. 4, pp. 573-589
Closed Access | Times Cited: 29

Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma
Bootsakorn Boonkaew, Nantawat Satthawiwat, Nutcha Pinjaroen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16043-16043
Open Access | Times Cited: 10

Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets
Ali Mahmoudi, Amin Jalili, Alexandra E. Butler, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 4, pp. 101365-101365
Closed Access | Times Cited: 3

Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations
Sarah Ashiqueali, Augusto Schneider, Xiang Zhu, et al.
Aging Cell (2024) Vol. 23, Iss. 9
Open Access | Times Cited: 3

Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
Reda Albadawy, Amany Helmy Hasanin, Sara H. A. Agwa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10148-10148
Open Access | Times Cited: 16

NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders
Maria Vulf, Maria Bograya, Alexandra Komar, et al.
Frontiers in Bioscience-Elite (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 9

The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Chunye Zhang, Shuai Liu, Ming Yang
Gastroenterology Insights (2022) Vol. 13, Iss. 2, pp. 148-161
Open Access | Times Cited: 15

Impact of miR-222-3p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation
Yoshiyuki Sakai, Tatsuki Fukami, Shinsaku Tokumitsu, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 56, pp. 101007-101007
Closed Access | Times Cited: 2

Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease
Ali Mahmoudi, Amin Jalili, Seyed Hamid Aghaee‐Bakhtiari, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 4, pp. 108722-108722
Closed Access | Times Cited: 2

Nonalcoholic Fatty Liver Disease and MicroRNAs
Sanjukta Mishra, Rajlaxmi Sarangi, Swarnalata Das, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2023) Vol. 7, Iss. 1, pp. 1-8
Open Access | Times Cited: 7

Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease
D. Terziev, D. Terzieva
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1722-1722
Open Access | Times Cited: 5

Core competing endogenous RNA network based on mRNA and non‐coding RNA expression profiles in chicken fatty liver
Qingxing Xiao, Yonghong Zhang, Hongyu Ni, et al.
Animal Genetics (2024) Vol. 55, Iss. 5, pp. 772-778
Closed Access | Times Cited: 1

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, et al.
Cureus (2021)
Open Access | Times Cited: 12

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients
Lui Ng, Ryan Wai‐Yan Sin, David Him Cheung, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9084-9084
Open Access | Times Cited: 3

Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat
Alfonso Quintás‐Cardama, Florian Caiment, Iván Rienda, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9298-9298
Open Access | Times Cited: 4

miR-195b is required for proper cellular homeostasis in the elderly
María del Mar Muñoz-Gallardo, Carlos García‐Padilla, Cristina Vicente‐García, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Effects of Flavonoids on Alcoholic Liver Disease: A Review
Xiaoqing Li, Yu Su, Xinyue Zhao, et al.
Food Reviews International (2024), pp. 1-28
Closed Access

The novel approach for non-invasive diagnostic biomarkers from an early stage of NAFLD to advanced fibrosis
Pooja Dudeja, Taishee Pal, Aman Sharma
Egyptian Liver Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Liver transcriptomics reveals microRNA features of the host response in a mouse model of dengue virus infection
Wenjiang Zheng, Ting Wang, Chengxin Liu, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106057-106057
Closed Access | Times Cited: 1

Page 1

Scroll to top